Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acura Pharmaceuticals Inc (NASDAQ:ACUR)

0.9101
Delayed Data
As of 9:30am ET
 -0.0198 / -2.13%
Today’s Change
0.85
Today|||52-Week Range
3.52
-63.60%
Year-to-Date
No recent news for Acura Pharmaceuticals Inc.

Today’s Trading

Previous close0.93
Today’s open0.93
Day’s range0.91 - 0.93
Volume722
Average volume (3 months)40,217
Market cap$11.0M
Dividend yield--
Data as of 9:30am ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+65.93%
Earnings growth (this year)-91.30%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,043.41%
P/E ratioNM
Price/Sales3.51
Price/Book1.33

Competitors

 Today’s
change
Today’s
% change
WINTWindtree Therapeutic...-0.02-1.47%
CLRBCellectar Bioscience...-0.05-3.57%
APRIApricus Biosciences ...-0.03-2.33%
PULMPulmatrix Inc+0.02+3.11%
Data as of 10:18am ET, 12/07/2016

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$8.6M
Annual profit (last year)-$5.0M
Net profit margin-58.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Robert B. Jones
CFO, Secretary, SVP &
Head-Investor Relations
Peter A. Clemens
Corporate headquarters
Palatine, Illinois

Forecasts


Search for Jobs